Petrus Bekker, SVP of Medical & Clinical at ChemoCentryx, Inc. (CCXI), sold 15,000 shares at $14.16 ($210K) on 2013-05-15, disclosed to the SEC on 2013-05-17.
Scheduled sale ($210k) by SVP of Medical & Clinical under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.16 | 10,000 | $142K | 67.6% |
| 2 | $13.59 | 5,000 | $68K | 32.4% |
| Total | $13.97 avg | 15,000 | $210K | 100% |
| Filing → |
| CCXI | SELL | 2017-06-30 | $760K | — | Filing → |
| CCXI | SELL | 2016-12-20 | $134K | — | Filing → |
| CCXI | SELL | 2016-12-07 | $255K | — | Filing → |